The Kalvistas Pharmaceuticals stock was up 1.2% to $1,814 per share on Friday.
The stock has been on a tear since its July 1 IPO, gaining 5.3% so far this year.
It’s been outperforming many other stocks.
In fact, Kalvistas shares were the highest of any pharmaceutical company in August.
The stock is up 9.7% in the last three months of the year.